Taipei, July 16 (CNA) The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
Ma Ying-jeou Foundation blames Tsai's policy failures for Honduras loss
03/26/2023 10:19 PM - Politics
Hondurans in Taiwan reckon with future after diplomatic split
03/26/2023 10:01 PM - Cross-Strait
Different motives seen behind Beijing's poaching of Honduras
03/26/2023 09:24 PM - Society
Drought conditions remain despite limited rainfall in southern Taiwan
03/26/2023 06:49 PM - Cross-Strait
MAC condemns Beijing after Honduras cuts ties with Taiwan
03/26/2023 06:35 PM